In Press
#01
Research
Molecular Docking of New Alpha-Glucosidase Inhibiting Anthracenone used Against Some Selected Type Ii Diabetes Receptors
Type II diabetes is a chronic metabolic disorder characterized by an impaired insulin action, early insulin resistance, and a decline and ultimate failure of be…
